You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

CLINICAL TRIALS PROFILE FOR SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sulfur Hexafluoride Lipid-type A Microspheres

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03040323 ↗ Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses Terminated Indiana University Phase 4 2016-12-22 The investigators plan to compare complication and success rates between two methods of ultrasound guidance for biopsy of liver lesions, contrast-enhanced and the current protocol without contrast.
NCT03300401 ↗ Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization Withdrawn National Cancer Institute (NCI) N/A 2017-11-07 This pilot clinical trial studies how well contrast-enhanced ultrasound in diagnosing patients with liver cancer who are undergoing Yttrium-90 radioembolization. Contrast-enhanced ultrasound may provide detailed imaging of the tumor arteries after the injection of a contrast-agent consisting of microbubbles, and may predict how much Yttrium-90 will deposit in the tumor.
NCT03300401 ↗ Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization Withdrawn University of Southern California N/A 2017-11-07 This pilot clinical trial studies how well contrast-enhanced ultrasound in diagnosing patients with liver cancer who are undergoing Yttrium-90 radioembolization. Contrast-enhanced ultrasound may provide detailed imaging of the tumor arteries after the injection of a contrast-agent consisting of microbubbles, and may predict how much Yttrium-90 will deposit in the tumor.
NCT03407001 ↗ Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis Completed National Cancer Institute (NCI) Early Phase 1 2018-01-12 This early phase I trial studies how well contrast enhanced ultrasound with sulfur hexafluoride lipid microspheres (Lumason) works in detecting liver cancer in participants with cirrhosis. Contrast enhanced-ultrasounds use contrast agents, such as Lumason, that are injected into a vein in order to help certain organs and tissues show up more clearly on scans. Contrast enhanced ultrasound with Lumason may help doctors more easily find liver cancer compared to ultrasounds without contrast agent.
NCT03407001 ↗ Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis Completed M.D. Anderson Cancer Center Early Phase 1 2018-01-12 This early phase I trial studies how well contrast enhanced ultrasound with sulfur hexafluoride lipid microspheres (Lumason) works in detecting liver cancer in participants with cirrhosis. Contrast enhanced-ultrasounds use contrast agents, such as Lumason, that are injected into a vein in order to help certain organs and tissues show up more clearly on scans. Contrast enhanced ultrasound with Lumason may help doctors more easily find liver cancer compared to ultrasounds without contrast agent.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sulfur Hexafluoride Lipid-type A Microspheres

Condition Name

Condition Name for Sulfur Hexafluoride Lipid-type A Microspheres
Intervention Trials
Hepatocellular Carcinoma 2
MIS-C 1
Acute Appendicitis 1
Necrotizing Enterocolitis of Newborn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sulfur Hexafluoride Lipid-type A Microspheres
Intervention Trials
Carcinoma, Hepatocellular 2
Carcinoma 2
Liver Diseases 2
Brain Ischemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sulfur Hexafluoride Lipid-type A Microspheres

Trials by Country

Trials by Country for Sulfur Hexafluoride Lipid-type A Microspheres
Location Trials
United States 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sulfur Hexafluoride Lipid-type A Microspheres
Location Trials
Pennsylvania 3
Indiana 2
Missouri 1
Texas 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sulfur Hexafluoride Lipid-type A Microspheres

Clinical Trial Phase

Clinical Trial Phase for Sulfur Hexafluoride Lipid-type A Microspheres
Clinical Trial Phase Trials
Phase 4 2
Phase 3 3
Phase 2 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sulfur Hexafluoride Lipid-type A Microspheres
Clinical Trial Phase Trials
Recruiting 4
Terminated 1
Active, not recruiting 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sulfur Hexafluoride Lipid-type A Microspheres

Sponsor Name

Sponsor Name for Sulfur Hexafluoride Lipid-type A Microspheres
Sponsor Trials
Children's Hospital of Philadelphia 3
Indiana University 2
National Cancer Institute (NCI) 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sulfur Hexafluoride Lipid-type A Microspheres
Sponsor Trials
Other 8
NIH 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.